ReviewOrthopedic research and reviews2026
Pes Anserine Bursitis: An Underrecognized Cause of Medial Knee Pain - A Review of Diagnosis, Associated Conditions, and Evidence-Based Management.
Review in Orthopedic research and reviews, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pes anserine bursitis (PAB) is a frequently underrecognized and misdiagnosed cause of medial knee pain. It occurs when there is inflammation of the bursa interposed between the conjoined pes anserine tendons and the underlying proximal tibia. The purpose of this review is to describe the current knowledge regarding the diagnosis and management of PAB by providing an evidence-based overview of clinical exams and treatment modalities. PAB is prevalent across several high-risk populations, including knee osteoarthritis (OA), obesity, type 2 diabetes mellitus, and athletes engaged in repetitive knee flexion activities. Diagnosis is currently limited by the absence of a validated quantitative clinical assessment tool. The main goal of treatment is to reduce associated bursal inflammation and address the underlying biomechanical and systemic contributing factors. The standard of care is conservative intervention, comprising rest, ice, and short-term NSAID use, then physical therapy and, where symptoms persist, intrabursal corticosteroid injection, with response commonly assessed at eight weeks. Surgery is considered only after these measures have been exhausted. Due to the complexity of overlapping medial knee pathology and the absence of a gold-standard diagnostic method, PAB remains a clinical diagnosis that requires thoughtful history-taking, physical examination, and selective use of imaging. This review summarizes essential clinical examination techniques and treatment options for PAB, emphasizing practical recommendations for orthopedic surgeons. The intended audience also includes sports medicine physicians, rehabilitation specialists, and primary care providers, as most cases are managed conservatively. Referral to orthopedic surgery is appropriate only when symptoms persist despite comprehensive conservative therapy. Although PAB is often diagnosed clinically, structural bursitis is confirmed in only a minority of cases, so management relies primarily on clinical assessment rather than imaging findings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.